The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases.

@article{Atzeni2010TheEO,
  title={The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases.},
  author={Fabiola Atzeni and Maurizio Turiel and R Caporali and Lorenzo Cavagna and Livio Tomasoni and Simona Sitia and Piercarlo Sarzi-Puttini},
  journal={Autoimmunity reviews},
  year={2010},
  volume={9 12},
  pages={
          835-9
        }
}
  • Fabiola Atzeni, Maurizio Turiel, +4 authors Piercarlo Sarzi-Puttini
  • Published in Autoimmunity reviews 2010
  • Medicine
  • The higher mortality rate among rheumatoid arthritis (RA) patients in comparison with the general population is largely attributable to cardiovascular (CV) disease, particularly coronary atherosclerosis, but also non-fatal myocardial infarction and heart failure. It may be due to RA-specific risk factors such as hyperhomocysteinemia, disease-related dyslipidemia or vascular inflammation, or morbidity related to high levels of cytokines such as tumour necrosis factor (TNF) and RA medications… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 46 CITATIONS

    Atherosclerosis and Rheumatoid Arthritis: More Than a Simple Association

    VIEW 14 EXCERPTS
    CITES BACKGROUND

    Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A

    VIEW 7 EXCERPTS
    CITES BACKGROUND & RESULTS
    HIGHLY INFLUENCED

    Diagnosis and management of rheumatoid arthritis.

    VIEW 8 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED